Parent Project Muscular Dystrophy and Action Duchenne hosted a webinar update on February 7, 2018 on the recent report that Summit has announced positive 24-week interim results from the open-label Phase 2 proof of concept clinical trial, PhaseOut DMD.
[Webinar] Positive Data from Summit's PhaseOUT DMD Ezutromid Clinical Trial - February 2018 duchenne muscular dystrophy treatment
Không có nhận xét nào:
Đăng nhận xét